PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.70%
Negative revenue growth while IXX.DE stands at 0.32%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-25.63%
Negative gross profit growth while IXX.DE is at 8.89%. Joel Greenblatt would examine cost competitiveness or demand decline.
-22.73%
Negative EBIT growth while IXX.DE is at 14.94%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-35.96%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-51.77%
Negative net income growth while IXX.DE stands at 74.43%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-51.81%
Negative EPS growth while IXX.DE is at 72.50%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-51.81%
Negative diluted EPS growth while IXX.DE is at 72.50%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
600.75%
Dividend growth above 1.5x IXX.DE's 94.49%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
16.25%
OCF growth under 50% of IXX.DE's 242.98%. Michael Burry might suspect questionable revenue recognition or rising costs.
31.42%
FCF growth under 50% of IXX.DE's 697.92%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
No Data
No Data available this quarter, please select a different quarter.
45.23%
5Y revenue/share CAGR at 75-90% of IXX.DE's 55.83%. Bill Ackman would encourage strategies to match competitor’s pace.
-0.75%
Negative 3Y CAGR while IXX.DE stands at 22.19%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.84%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
No Data
No Data available this quarter, please select a different quarter.
136.12%
5Y net income/share CAGR 1.25-1.5x IXX.DE's 97.17%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
-73.41%
Negative 3Y CAGR while IXX.DE is 1130.06%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
135.13%
5Y equity/share CAGR above 1.5x IXX.DE's 27.77%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
13.16%
3Y equity/share CAGR at 50-75% of IXX.DE's 24.23%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
28.12%
Dividend/share CAGR of 28.12% while IXX.DE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
30.40%
3Y dividend/share CAGR of 30.40% while IXX.DE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
No Data
No Data available this quarter, please select a different quarter.
-17.87%
Inventory is declining while IXX.DE stands at 0.45%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.26%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-3.75%
We have a declining book value while IXX.DE shows 6.47%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
12.92%
We have some new debt while IXX.DE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-20.48%
We cut SG&A while IXX.DE invests at 27.19%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.